{
  "claim_id": "claim_007",
  "claim": "Recombinant HA antigens produced using BEVS have been shown to induce significantly higher levels of broadly cross-reactive antibodies against highly conserved regions of HA compared with egg-derived vaccines.",
  "document": "Arunachalam_et_al.__2021_",
  "verification_stats": {
    "total_extracted": 6,
    "verified": 2,
    "rejected": 4,
    "verification_rate": 0.3333333333333333
  },
  "verified_evidence": [
    {
      "id": 1,
      "quote": "Portnoff et al.64 demonstrated that recombinant HA antigens (specifically for the H3 strain) produced using BEVS (as used for RIV4), induced significantly higher levels of broadly cross reactive antibodies against highly conserved regions of the HA head and stem in both mice and humans compared to egg derived split vaccines 64.",
      "supports_claim": true,
      "explanation": "A semantically equivalent quote appears on page 5: 'Portnoff et al.64 demonstrated that recombinant HA antigens (specifically for the H3 strain) produced using BEVS (as used for RIV4), induced significantly higher levels of broadly cross reactive antibodies against highly conserved regions of the HA head and stem ...dli i 64'. The ellipsis in the OCR text likely represents a line break or missing text, but the key facts and structure of the quote are present and match the provided quote.. The quote directly states that recombinant HA antigens produced using BEVS (as used for RIV4) induced significantly higher levels of broadly cross-reactive antibodies against highly conserved regions of the HA head and stem compared to egg-derived split vaccines. This directly and explicitly supports the claim, as it addresses both the use of BEVS, the comparison to egg-derived vaccines, and the induction of broadly cross-reactive antibodies to conserved HA regions.",
      "presence_explanation": "A semantically equivalent quote appears on page 5: 'Portnoff et al.64 demonstrated that recombinant HA antigens (specifically for the H3 strain) produced using BEVS (as used for RIV4), induced significantly higher levels of broadly cross reactive antibodies against highly conserved regions of the HA head and stem ...dli i 64'. The ellipsis in the OCR text likely represents a line break or missing text, but the key facts and structure of the quote are present and match the provided quote.",
      "support_explanation": "The quote directly states that recombinant HA antigens produced using BEVS (as used for RIV4) induced significantly higher levels of broadly cross-reactive antibodies against highly conserved regions of the HA head and stem compared to egg-derived split vaccines. This directly and explicitly supports the claim, as it addresses both the use of BEVS, the comparison to egg-derived vaccines, and the induction of broadly cross-reactive antibodies to conserved HA regions.",
      "original_relevance": "This quote directly states that recombinant HA antigens produced using BEVS induce significantly higher levels of broadly cross-reactive antibodies against highly conserved regions of HA compared to egg-derived vaccines, explicitly supporting the claim."
    },
    {
      "id": 3,
      "quote": "In a study by Nachbagauer et al.78, RIV4 induced HA stem specific neutralising antibodies directed against influenza subtypes H1, H3 and B haemagglutinin in an age dependent manner in humans, with the highest titres observed in the elderly 78. RIV4 also induces antibodies, in both humans and mice, that are specific to epitopes in the HA head region, at greater proportions than a traditional mammalian cell derived subunit vaccine (Flucelvax [Trivalent] 77. Higher magnitudes of haemagglutination inhibitory antibody response against HA1 have also been observed with RIV4 compared to egg- or mammalian cell derived split vaccines (Flucelvax Tetra, Seqirus, and Fluzone quadrivalent SD, Sanofi Pasteur 60.",
      "supports_claim": true,
      "explanation": "The quote appears on page 5 of the document, with only minor differences in formatting and punctuation. The factual content is preserved: 'In a study by Nachbagauer et al.78, RIV4 induced HA stem specific neutralising antibodies directed against influenza subtypes H1, H3 and B haemagglutinin in an age dependent manner in humans, with the highest titres observed in the elderly 78. RIV4 also induces antibodies, in both humans and mice, that are specific to epitopes in the HA head region, at greater proportions than a traditional mammalian cell derived subunit vaccine (Flucelvax [Trivalent] 77. Higher magnitudes of haemagglutination inhibitory antibody response against HA1 have also been observed with RIV4 compared to egg- or mammalian cell derived split vaccines (Flucelvax Tetra, Seqirus, and Fluzone quadrivalent SD, Sanofi Pasteur 60.' The content and meaning are equivalent to the quote provided.. The quote directly supports the claim. It states that RIV4 (a BEVS-produced recombinant HA vaccine) induces higher levels of broadly cross-reactive antibodies, including those specific to highly conserved regions of HA (the stem and head), compared to both egg-derived and mammalian cell-derived vaccines. It also notes that these effects are observed in both humans and mice, and that the highest titres are seen in the elderly. This directly substantiates the claim that BEVS-produced recombinant HA antigens induce significantly higher levels of broadly cross-reactive antibodies against highly conserved regions of HA compared with egg-derived vaccines.",
      "presence_explanation": "The quote appears on page 5 of the document, with only minor differences in formatting and punctuation. The factual content is preserved: 'In a study by Nachbagauer et al.78, RIV4 induced HA stem specific neutralising antibodies directed against influenza subtypes H1, H3 and B haemagglutinin in an age dependent manner in humans, with the highest titres observed in the elderly 78. RIV4 also induces antibodies, in both humans and mice, that are specific to epitopes in the HA head region, at greater proportions than a traditional mammalian cell derived subunit vaccine (Flucelvax [Trivalent] 77. Higher magnitudes of haemagglutination inhibitory antibody response against HA1 have also been observed with RIV4 compared to egg- or mammalian cell derived split vaccines (Flucelvax Tetra, Seqirus, and Fluzone quadrivalent SD, Sanofi Pasteur 60.' The content and meaning are equivalent to the quote provided.",
      "support_explanation": "The quote directly supports the claim. It states that RIV4 (a BEVS-produced recombinant HA vaccine) induces higher levels of broadly cross-reactive antibodies, including those specific to highly conserved regions of HA (the stem and head), compared to both egg-derived and mammalian cell-derived vaccines. It also notes that these effects are observed in both humans and mice, and that the highest titres are seen in the elderly. This directly substantiates the claim that BEVS-produced recombinant HA antigens induce significantly higher levels of broadly cross-reactive antibodies against highly conserved regions of HA compared with egg-derived vaccines.",
      "original_relevance": "This quote details that RIV4, a BEVS-produced recombinant HA vaccine, induces higher levels of antibodies specific to conserved regions of HA compared to egg-derived vaccines, directly supporting the claim."
    }
  ],
  "rejected_evidence": [
    {
      "id": 2,
      "quote": "Recently Richards et al.65 examined CD4 T-cell and antibody responses in healthy adults who received egg derived split vaccine, cell derived split vaccine or RIV4 for three successive influenza seasons (2015-2016, 2016-2017, and 2017-2018 65. RIV4 elicited the most robust responses, with significantly higher T-cell and antibody levels than the other two vaccines. Authors postulated that simpler glycosylation of rHA and absence of other influenza viral proteins in RIV4 contributed to the observed robust immune response for RIV4 and emphasised the relevance of these features in determining vaccine efficacy and long term immunity 65.",
      "reason": "does not support claim",
      "original_explanation": "This quote provides evidence from a comparative study showing that RIV4 (a BEVS-produced recombinant HA vaccine) induces significantly higher antibody responses than egg-derived vaccines, supporting the claim of superior induction of broadly cross-reactive antibodies."
    },
    {
      "id": "comp_1",
      "quote": "Contrary to the egg derived vaccines and as expected, rHA containing the new glycosylation site induced optimal levels of antibodies that efficiently recognised the glycosylated clade 3 C.2 a H3 N2 virus 26.",
      "reason": "does not support claim",
      "original_explanation": "This quote provides direct evidence that recombinant HA (rHA) antigens produced using BEVS induce optimal levels of antibodies that efficiently recognize conserved viral regions, in contrast to egg-derived vaccines, supporting the claim of broader cross-reactivity."
    },
    {
      "id": "comp_2",
      "quote": "The higher quantity and greater accessibility of the genetically conserved stem region of rHA produced in insect cells (resulting in smaller N-linked glycans) may contribute to cross protection against mismatched influenza strains 12 75.",
      "reason": "does not support claim",
      "original_explanation": "This statement links the structural features of BEVS-produced rHA to the induction of cross-protective antibodies against conserved regions, supporting the claim that these vaccines induce higher levels of broadly cross-reactive antibodies compared to egg-derived vaccines."
    },
    {
      "id": "comp_3",
      "quote": "Thus, elimination of parts of glycans that are not essential for HA structure may improve vaccine induced protection. Subsequent studies showed that HA with simpler glycans induce more broadly protective antibodies with superior cross clade protection compared to HA with more complex glycans76-79.",
      "reason": "does not support claim",
      "original_explanation": "This quote supports the claim by stating that recombinant HA with simpler glycans (as produced in BEVS) induces more broadly protective antibodies than HA with complex glycans, which are typical of egg-derived vaccines."
    }
  ],
  "model_used": "gpt-4.1"
}